Related Experiment Video
Updated: Apr 17, 2026

09:00
Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition
Published on: June 16, 2019
10.2K
Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem
Senquan Liu1, Yulin Xu2, Zijing Zhou3
1Bone Marrow Transplantation Centre, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Cytotherapy
|February 15, 2015
Summary
Generating functional hematopoietic stem cells (HSCs) from human pluripotent stem cells (hPSCs) is key for transplantation. This review covers challenges and solutions for efficient in vitro HSC generation.
Area of Science:
- Stem cell biology
- Hematopoiesis
- Regenerative medicine
Background:
- Human pluripotent stem cells (hPSCs) offer a potential source for hematopoietic stem cells (HSCs) for transplantation.
- Current methods for generating hPSC-derived HSCs have low efficiency and functional deficits, limiting clinical application.
- Understanding the molecular mechanisms underlying hematopoietic differentiation is crucial.
Purpose of the Study:
- To review the current state of in vitro hematopoietic differentiation from hPSCs.
- To highlight molecular mechanisms causing aberrant phenotypes and functions in hPSC-derived hematopoietic cells.
- To identify challenges and explore solutions for generating clinically applicable HSCs from hPSCs.
Main Methods:
- Literature review of in vitro hematopoietic differentiation protocols.
- Analysis of intrinsic and extrinsic molecular factors influencing hPSC differentiation.
- Evaluation of current challenges and potential strategies for functional HSC generation.
Main Results:
- In vitro hematopoietic differentiation protocols face challenges in efficiency and functional maturity of HSCs.
- Aberrant phenotypes and functions in hPSC-derived hematopoietic cells are linked to specific molecular mechanisms.
- Significant hurdles remain in achieving full hematopoietic reconstitution capacity.
Conclusions:
- Developing efficient and reliable methods for generating functional HSCs from hPSCs is critical for clinical transplantation.
- Addressing molecular dysregulations and optimizing differentiation protocols are key to overcoming current limitations.
- Further research into intrinsic and extrinsic factors is needed to unlock the full therapeutic potential of hPSC-derived HSCs.
Keywords:
hematopoietic differentiationhematopoietic reconstitutionhematopoietic stem cellshuman embryonic stem cellsinduced pluripotent stem cells
